Concepedia

KW Mahaffey

KM

Statistics

Publications

4

Citations

127

H-Index

4

Active since

2000

Affiliations

Clinical Research Institute(Current)

KW Mahaffey is an author at Clinical Research Institute specializing in medicine, cardiovascular pharmacotherapy, and pharmacotherapy.

Publications per year

2000–2019

4

Publications

4

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

Kevin R. Campbell, KW Mahaffey, Bruce Lewis et al. · PubMed · 2000 · 68 citations

Medicine, Cardiology, Hematology +14

Efficacy and safety of Canagliflozin (CANA), an inhibitor of Sodium Glucose Co-Transporter 2 (SGLT2), added on to insulin therapy with or without oral agents in type 2 diabetes (T2D)

D. M. Matthews, Gregory Fulcher, Vlado Perkovic et al. · Diabetologie und Stoffwechsel · 2013 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: A systematic overview

J.L. Petersen, KW Mahaffey, V. Hasselbladet · ACC Current Journal Review · 2004 · 23 citations

Medicine, Cardiology, Internal Medicine +17

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial

CP Cannon, Perkovic, Rupesh Agarwal et al. · 2019 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–4 of 4